WOCKPHARMA.NS

Wockhardt Limited WOCKPHARMA.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode WOCKPHARMA.NS ERIS.BO ERIS.NS ASTRAZEN.NS ASTRAZEN.BO NEULANDLAB.NS NEULANDLAB.BO PEL.NS JBCHEPHARM.NS JBCHEPHARM.BO
6M -2.72 % 13.42 % 13.30 % 3.73 % 4.01 % 24.44 % 24.08 % 9.10 % 2.10 % 2.24 %
YTD -5.70 % 19.10 % 19.09 % 29.33 % 29.07 % 13.80 % 13.43 % 2.70 % -9.98 % -9.87 %
1Y 34.62 % 24.27 % 24.56 % 29.43 % 29.49 % 21.82 % 21.67 % 9.61 % -11.03 % -10.86 %
3Y 471.84 % 115.10 % 115.57 % 201.02 % 201.61 % 984.72 % 983.00 % 33.43 % 70.78 % 71.11 %
5Y 367.70 % 210.94 % 217.51 % 120.04 % 121.19 % 1 264.45 % 1 264.17 % 55.43 % 64.50 % 225.45 %
10Y -12.56 % 163.84 % 163.59 % 648.80 % 649.58 % 1 941.28 % 1 939.06 % 114.64 % 468.26 % 1 039.25 %
From the beginning 742.92 % 163.84 % 163.59 % 31 235.02 % 15 936.47 % 14 585.38 % 10 570.53 % 4 306.90 % 7 309.29 % 82 858.33 %

Dividend

Wockhardt Limited

Eris Lifesciences Limited

Eris Lifesciences Limited

AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited

Neuland Laboratories Limited

Neuland Laboratories Limited

Piramal Enterprises Limited

J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited